Human adenovirus e serotype 4 strain cl-68578 antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Human adenovirus e serotype 4 strain cl-68578 antigen
Accession Number
DB14409
Description

Human adenovirus e serotype 4 strain cl-68578 antigen is a vaccine.

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Other vaccines
Synonyms
  • Adenovirus Type 4 Strain Cl-68578
  • Adenovirus Type 4 Vaccine Live
  • Adenovirus Vaccine, Live, Oral, Type 4
  • Human Adenovirus E Serotype 4 Strain Cl-68578
  • Human Adenovirus Serotype 4 Strain Cl-68578
  • Human Adenovirus Serotype 4 Vaccine Strain Cl-68578
  • Mastadenovirus Human Adenovirus B Type 4 Strain Cl-68578

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbacavirThe therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Abacavir.
AbataceptThe risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Abatacept.
AcyclovirThe therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Acyclovir.
AdalimumabThe risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Adalimumab.
Adefovir dipivoxilThe therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Adefovir dipivoxil.
AldesleukinThe risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Aldesleukin.
AlefaceptThe risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Alefacept.
AlemtuzumabThe risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Alemtuzumab.
AltretamineThe risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Altretamine.
AmantadineThe therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Amantadine.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Adenovirus Type 4 and Type 7 Vaccine, LiveHuman adenovirus e serotype 4 strain cl-68578 antigen (32000 [TCID_50]/1) + Adenovirus type 7 vaccine live (32000 [TCID_50]/1)OralTeva Women's Health, Inc.2011-09-16Not applicableUS flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
FKD3DUK39I
CAS number
Not Available

References

General References
Not Available
RxNav
1099933

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 05, 2018 18:02 / Updated on June 12, 2020 16:53